Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 336  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
E-IJD® - ORIGINAL ARTICLE
Year : 2022  |  Volume : 67  |  Issue : 5  |  Page : 625

Assessment of the efficacy and safety of 30% supramolecular salicylic acid peeling for papulopustular rosacea treatment


1 Department of Dermatology, The Second Affiliated Hospital of Fujian Medical University, No. 950, Donghai Avenue, Quanzhou City, Fujian Province, China
2 Department of Neurology, The Second Affiliated Hospital of Fujian Medical University, No. 950, Donghai Avenue, Quanzhou City, Fujian Province, China

Correspondence Address:
Linghui Xu
Department of Dermatology, The Second Affiliated Hospital of Fujian Medical University, No. 950, Donghai Avenue, Quanzhou City, Fujian Province - 362000
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijd.ijd_353_21

Rights and Permissions

Background: Thirty per cent supramolecular salicylic acid (SSA) is a water-soluble, sustained release salicylic acid (SA) modality, which is well tolerated by sensitive skin. Anti-inflammatory therapy plays an important role in papulopustular rosacea (PPR) treatment. SSA at a 30% concentration has a natural antiinflammatory property. Aims: This study aims to investigate the efficacy and safety of 30% SSA peeling for PPR treatment. Methods: Sixty PPR patients were randomly divided into two groups: SSA group (30 cases) and control group (30 cases). Patients of the SSA group were treated with 30% SSA peeling three times every 3 weeks. Patients in both groups were instructed to topically apply 0.75% metronidazole gel twice daily. Transdermal water loss (TEWL), skin hydration and erythema index were assessed after 9 weeks. Results: Fifty-eight patients completed the study. The improvement of erythema index in the SSA group was significantly better than that in the control group. No significant difference was found in terms of TEWL between the two groups. The content of skin hydration in both the groups increased, but there was no statistical significance. No severe adverse events were observed in both the groups. Conclusion: SSA can significantly improve the erythema index and overall appearance of skin in rosacea patients. It has a good therapeutic effect, good tolerance and high safety.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed456    
    Printed10    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal